About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Revlimid Approved By FDA For Multiple Myeloma

by Medindia Content Team on July 6, 2006 at 10:02 AM
Font : A-A+

Revlimid Approved By FDA For Multiple Myeloma

The U.S. Food and Drug Administration has approved the anemia drug Revlimid (lenalidomide) as a treatment for multiple myeloma, which is a type of blood cancer.

Celgene Corp, which makes this drug will now be able to market Revlimid for use in multiple myeloma. The treatment regimen demands that the drug be combined with the steroid dexamethasone in patients with multiple myeloma, who have earlier been treated with chemotherapy.

Advertisement

The approval was given after the results of clinical trials in which patients who took Revlimid and dexamethasone survived an average of 29.6 months. In contrast patients on dexamethasone and placebo survived only 20.2 months.

It is estimated that multiple myeloma affects 50,000 people in the United States, while 14,000 new cases are diagnosed every year.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Multiple Myeloma 

Most Popular on Medindia

Drug - Food Interactions Drug Side Effects Calculator Post-Nasal Drip Calculate Ideal Weight for Infants Find a Hospital The Essence of Yoga A-Z Drug Brands in India Vent Forte (Theophylline) Loram (2 mg) (Lorazepam) Selfie Addiction Calculator
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Revlimid Approved By FDA For Multiple Myeloma Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests